e-Article
A phase 3, randomized, placebo- controlled, double-blind study to investigate the long-term safety and tolerability of fezolinetant in women seeking treatment for vasomotor symptoms associated with menopause (SKYLIGHT 4)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15300374